超声介入配合药物治疗子宫内膜异位囊肿的临床分析

Clinical analysis of interventional ultrasound combined with medicine on the treatment of endometriosis cyst

目的 观察超声介入配合药物治疗在子宫内膜异位囊肿中的应用,评价其疗效。方法 选取余姚市第二人民医院2014年4月-2017年3月收治的76例子宫内膜异位囊肿患者为研究对象,随机分为参照组与研究组各38例,参照组给予患者单用超声介入治疗,研究组在参照组基础上给予口服米非司酮,2组均治疗3个月,观察其临床疗效。结果 2组患者超声引导下穿刺均一次成功,研究组治疗总有效率97.37%（37/38）,参照组治疗总有效率84.21%（32/38）,2组差异具有统计学意义（P〈0.05）;研究组复发率7.89%（3/38）、副作用发生率10.53%（4/38）,均明显低于参照的15.79%（6/38）、21.05%（8/38）,差异具有统计学意义（P〈0.05）。结论 超声介入配合口服米非司酮应用于子宫内膜异位囊肿的治疗中疗效确切,且治疗后复发率与副反应均较低,安全性更高,具有临床应用与推广价值。

Objective To observe the clinical application of interventional ultrasound combined with medicine on the treatment of endometriosis cyst , and evaluate its clinical curative effect. Methods 76 cases with endometriosis in Yuyao the second people＆#39;s hospital from April 2014 to March 2017 were randomly divided into the control group and the study group with 38 cases in each group. The control group were given interventional ultrasonic, the study group were received oral mifepristone on the basis of the treatment in the control group. The two groups were received treatment for a period of three months, the effect in the two groups was observed. Results The two groups were successfully puctured guided by ultrasound for the first time. The total effective rate in the study group was 97.37%（37/38）, and 84.21%（32/38） in the control group, the difference between the two groups had statistically significant （P〈0.05）; The recurrence rate in the study group was 7.89%（3/38） and the adverse reaction rate was10.53%（4/38）, which was significantly lower than those in the control group 15.79（6/38） and 21.05%（8/38）, the differences was statistically significant （P〈0.05）. Conclusion Ultrasound intervention combined with oral mifepristone on the treatment of endometriosis cyst is effective, the recurrence rate and the side effects are low, which was higher security, and has clinical application and promotion value.